Unknown

Dataset Information

Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.


ABSTRACT:

Purpose of review

As the incidence of calcific aortic valve stenosis increases with the aging of the population, improved understanding and novel therapies to reduce its progression and need for aortic valve replacement are urgently needed.

Recent findings

Lipoprotein(a) is the only monogenetic risk factor for calcific aortic stenosis. Elevated levels are a strong, causal, independent risk factor, as demonstrated in epidemiological, genome-wide association studies and Mendelian randomization studies. Lipoprotein(a) is the major lipoprotein carrier of oxidized phospholipids, which are proinflammatory and promote calcification of vascular cells, two key pathophysiological drivers of aortic stenosis. Elevated plasma lipoprotein(a) and oxidized phospholipids predict progression

SUBMITTER: Yeang C 

PROVIDER: S-EPMC4956483 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature